"pharmaceutical formulation, and use of a pharmaceutically effective amount of a pharmaceutical formulation."

• 收藏
• 分享

专利权人:

NORDIC BIOSCIENCE A/S

发明人:

CLAUS CHRISTIANSEN,MORTEN ASSER KARSDAL

申请号：

BRPI1009392

公开号：

BRPI1009392A2

申请日:

2010.03.10

申请国别(地区):

BR

年份:

2016

代理人:

摘要：

Enterally administered calcitonin family members other than amylin, particularly calcitonin itself, are effective to treat Type I diabetes, Type II diabetes or metabolic syndrome, for mitigating insulin resistance, and for reducing serum glucose levels.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/